<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>73(5)</volume><submitter>Patlolla SH</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To evaluate the prevalence and impact of respiratory infections in cardiogenic shock complicating acute myocardial infarction (AMI-CS).&lt;h4>Methods&lt;/h4>Using the National Inpatient Sample (2000-2017), this study identified adult (≥18 years) admitted with AMI-CS complicated by respiratory infections. Outcomes of interest included in-hospital mortality of AMI-CS admissions with and without respiratory infections, hospitalization costs, hospital length of stay, and discharge disposition. Temporal trends of prevalence, in-hospital mortality and cardiac procedures were evaluated.&lt;h4>Results&lt;/h4>Among 557,974 AMI-CS admissions, concomitant respiratory infections were identified in 84,684 (15.2%). Temporal trends revealed a relatively stable trend in prevalence of respiratory infections over the 18-year period. Admissions with respiratory infections were on average older, less likely to be female, with greater comorbidity, had significantly higher rates of NSTEMI presentation, and acute non-cardiac organ failure compared to those without respiratory infections (all p &lt; 0.001). These admissions received lower rates of coronary angiography (66.8% vs 69.4%, p &lt; 0.001) and percutaneous coronary interventions (44.8% vs 49.5%, p &lt; 0.001), with higher rates of mechanical circulatory support, pulmonary artery catheterization, and invasive mechanical ventilation compared to AMI-CS admissions without respiratory infections (all p &lt; 0.001). The in-hospital mortality was lower among AMI-CS admissions with respiratory infections (31.6% vs 38.4%, adjusted OR 0.58 [95% CI 0.57-0.59], p &lt; 0.001). Admissions with respiratory infections had longer lengths of hospital stay (12&lt;sup>7-20&lt;/sup> vs 6&lt;sup>3-11&lt;/sup> days, p &lt; 0.001), higher hospitalization costs and less frequent discharges to home (27.1% vs 44.7%, p &lt; 0.001).&lt;h4>Conclusions&lt;/h4>Respiratory infections in AMI-CS admissions were associated with higher resource utilization but lower in-hospital mortality.</pubmed_abstract><journal>Indian heart journal</journal><pagination>565-571</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8514410</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of concomitant respiratory infections in the management and outcomes acute myocardial infarction-cardiogenic shock.</pubmed_title><pmcid>PMC8514410</pmcid><pubmed_authors>Patlolla SH</pubmed_authors><pubmed_authors>Vallabhajosyula S</pubmed_authors><pubmed_authors>Sundaragiri PR</pubmed_authors><pubmed_authors>Cheungpasitporn W</pubmed_authors><pubmed_authors>Doshi R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of concomitant respiratory infections in the management and outcomes acute myocardial infarction-cardiogenic shock.</name><description>&lt;h4>Objective&lt;/h4>To evaluate the prevalence and impact of respiratory infections in cardiogenic shock complicating acute myocardial infarction (AMI-CS).&lt;h4>Methods&lt;/h4>Using the National Inpatient Sample (2000-2017), this study identified adult (≥18 years) admitted with AMI-CS complicated by respiratory infections. Outcomes of interest included in-hospital mortality of AMI-CS admissions with and without respiratory infections, hospitalization costs, hospital length of stay, and discharge disposition. Temporal trends of prevalence, in-hospital mortality and cardiac procedures were evaluated.&lt;h4>Results&lt;/h4>Among 557,974 AMI-CS admissions, concomitant respiratory infections were identified in 84,684 (15.2%). Temporal trends revealed a relatively stable trend in prevalence of respiratory infections over the 18-year period. Admissions with respiratory infections were on average older, less likely to be female, with greater comorbidity, had significantly higher rates of NSTEMI presentation, and acute non-cardiac organ failure compared to those without respiratory infections (all p &lt; 0.001). These admissions received lower rates of coronary angiography (66.8% vs 69.4%, p &lt; 0.001) and percutaneous coronary interventions (44.8% vs 49.5%, p &lt; 0.001), with higher rates of mechanical circulatory support, pulmonary artery catheterization, and invasive mechanical ventilation compared to AMI-CS admissions without respiratory infections (all p &lt; 0.001). The in-hospital mortality was lower among AMI-CS admissions with respiratory infections (31.6% vs 38.4%, adjusted OR 0.58 [95% CI 0.57-0.59], p &lt; 0.001). Admissions with respiratory infections had longer lengths of hospital stay (12&lt;sup>7-20&lt;/sup> vs 6&lt;sup>3-11&lt;/sup> days, p &lt; 0.001), higher hospitalization costs and less frequent discharges to home (27.1% vs 44.7%, p &lt; 0.001).&lt;h4>Conclusions&lt;/h4>Respiratory infections in AMI-CS admissions were associated with higher resource utilization but lower in-hospital mortality.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep-Oct</publication><modification>2024-11-09T16:17:19.876Z</modification><creation>2024-11-09T16:17:19.876Z</creation></dates><accession>S-EPMC8514410</accession><cross_references><pubmed>34627570</pubmed><doi>10.1016/j.ihj.2021.07.004</doi></cross_references></HashMap>